Business Description
Embla Medical hf
ISIN : IS0000000040
Compare
Compare
Traded in other countries / regions
EMBLA.DenmarkOSSFF.USA0FIW.UK IPO Date
2009-09-04Description
Embla Medical hf is a provider of prosthetics and bracing and supports solutions; FIOR & GENTZ, an innovative developer of neuro orthotics; and College Park, creators of custom-built prosthetic solutions for people of all activity levels..
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.15 | |||||
| Equity-to-Asset | 0.5 | |||||
| Debt-to-Equity | 0.69 | |||||
| Debt-to-EBITDA | 3.22 | |||||
| Interest Coverage | 4.94 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 3.28 | |||||
| Beneish M-Score | -2.56 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.9 | |||||
| 3-Year EBITDA Growth Rate | 23 | |||||
| 3-Year EPS without NRI Growth Rate | 119.9 | |||||
| 3-Year FCF Growth Rate | -5 | |||||
| 3-Year Book Growth Rate | 11.2 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.65 | |||||
| 9-Day RSI | 45.56 | |||||
| 14-Day RSI | 47.64 | |||||
| 6-1 Month Momentum % | 31.02 | |||||
| 12-1 Month Momentum % | 30.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.99 | |||||
| Quick Ratio | 1.26 | |||||
| Cash Ratio | 0.4 | |||||
| Days Inventory | 163.06 | |||||
| Days Sales Outstanding | 56.13 | |||||
| Days Payable | 37.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | -1.96 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 62.02 | |||||
| Operating Margin % | 12.51 | |||||
| Net Margin % | 8.21 | |||||
| FCF Margin % | 8.21 | |||||
| ROE % | 9.43 | |||||
| ROA % | 4.64 | |||||
| ROIC % | 5.94 | |||||
| ROC (Joel Greenblatt) % | 31.46 | |||||
| ROCE % | 8.7 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 31.89 | |||||
| PE Ratio without NRI | 31.89 | |||||
| Shiller PE Ratio | 32.51 | |||||
| Price-to-Owner-Earnings | 23.68 | |||||
| PEG Ratio | 11 | |||||
| PS Ratio | 2.65 | |||||
| PB Ratio | 2.86 | |||||
| Price-to-Free-Cash-Flow | 32.18 | |||||
| Price-to-Operating-Cash-Flow | 20.1 | |||||
| EV-to-EBIT | 24.21 | |||||
| EV-to-EBITDA | 16.27 | |||||
| EV-to-Revenue | 3.2 | |||||
| EV-to-FCF | 38.94 | |||||
| Price-to-Projected-FCF | 1.79 | |||||
| Price-to-DCF (Earnings Based) | 1.98 | |||||
| Price-to-DCF (FCF Based) | 1.99 | |||||
| Price-to-Median-PS-Value | 0.78 | |||||
| Price-to-Peter-Lynch-Fair-Value | 5.61 | |||||
| Earnings Yield (Greenblatt) % | 4.13 | |||||
| FCF Yield % | 3.13 | |||||
| Forward Rate of Return (Yacktman) % | 8.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Embla Medical hf Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 5,744.778 | ||
| EPS (TTM) (kr) | 1.107 | ||
| Beta | 0.2 | ||
| Volatility % | 25.64 | ||
| 14-Day RSI | 47.64 | ||
| 14-Day ATR (kr) | 1.190757 | ||
| 20-Day SMA (kr) | 35.855 | ||
| 12-1 Month Momentum % | 30.07 | ||
| 52-Week Range (kr) | 26 - 38 | ||
| Shares Outstanding (Mil) | 426.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Embla Medical hf Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Embla Medical hf Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Embla Medical hf Frequently Asked Questions
What is Embla Medical hf(OCSE:EMBLA)'s stock price today?
The current price of OCSE:EMBLA is kr35.30. The 52 week high of OCSE:EMBLA is kr38.00 and 52 week low is kr26.00.
When is next earnings date of Embla Medical hf(OCSE:EMBLA)?
The next earnings date of Embla Medical hf(OCSE:EMBLA) is 2025-02-05.
Does Embla Medical hf(OCSE:EMBLA) pay dividends? If so, how much?
Embla Medical hf(OCSE:EMBLA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers